Did You Lose Money on Your Sangamo Therapeutics Investment? Contact Levi & Korsinsky for an Active Investigation!
New York, NY / ACCESSWIRE / January 6, 2025
Levi & Korsinsky notifies investors that it has commenced an investigation of Sangamo Therapeutics, Inc. (“Sangamo Therapeutics, Inc.”) (NASDAQ:SGMO) concerning possible violations of federal securities laws. Sangamo announced on December 30, 2024, that Pfizer, with whom the Company was co-developing hemophilia A gene therapy candidate giroctocogene fitelparvovec, would be returning after the development and commercialization rights to giroctocogene fitelparvovec after deciding not to pursue commercialization of the asset, which is in phase 3.
Investing in the stock market can be a risky endeavor. When news like the one involving Sangamo Therapeutics and Pfizer breaks, investors are often left wondering about the future of their investments. Sangamo Therapeutics had high hopes for their hemophilia A gene therapy candidate, but with Pfizer pulling out, the company’s stock took a hit.
Whether you are a seasoned investor or just starting out, losing money on an investment can be a tough pill to swallow. That’s where Levi & Korsinsky comes in. They specialize in investigating possible violations of federal securities laws and holding companies accountable for their actions.
How Will This Affect Me?
If you are one of the investors who lost money on your Sangamo Therapeutics investment, contacting Levi & Korsinsky for an active investigation could potentially help you recoup some of your losses. By getting involved in the investigation, you may be able to hold the company accountable for any wrongdoings and seek compensation for your losses.
How Will This Affect the World?
The news of Pfizer returning the development and commercialization rights to giroctocogene fitelparvovec could have a ripple effect in the world of biotech and pharmaceuticals. It could potentially impact the future of gene therapy research and development, as well as partnerships between companies working on cutting-edge treatments. Investors in the industry may also become more cautious when considering investments in similar projects.
Conclusion
Investing in the stock market always comes with risks, but when unexpected news like the Sangamo Therapeutics and Pfizer situation arises, it can be especially challenging. If you find yourself in a situation where you have lost money on your investment, reaching out to Levi & Korsinsky for an active investigation could be a step towards seeking justice and potentially recovering some of your losses.
